| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Incyte Corporation | COM | 45337C102 | $2,271,687,070 | 36,179,122 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $1,906,206,263 | 10,568,897 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $1,342,091,002 | 42,864,612 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $455,771,861 | 1,969,798 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $294,132,839 | 6,398,365 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $242,134,600 | 4,121,440 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $172,216,342 | 2,520,731 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $152,656,327 | 5,995,928 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $147,663,483 | 5,148,657 | SOLE | |||
| Invitae Corporation | Notes 1.5% 4/1/2028 | 46185LAD5 | $131,152,500 | 300,000,000 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $130,814,690 | 22,909,753 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $85,269,660 | 7,593,024 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $80,467,182 | 9,545,336 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $73,425,209 | 4,865,819 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $70,130,278 | 1,466,547 | SOLE | |||
| Cerevel Therapeutics Holdings, Inc. | COM | 15678U128 | $67,840,000 | 1,600,000 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $61,483,122 | 5,838,853 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $60,655,794 | 10,126,176 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $57,526,722 | 151,215 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $55,950,426 | 2,607,196 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $55,301,626 | 2,368,378 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $52,623,890 | 17,310,490 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $49,279,981 | 2,809,577 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $45,768,855 | 993,679 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $43,228,728 | 10,123,824 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $42,071,052 | 19,477,339 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $40,063,530 | 3,882,125 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $38,030,100 | 1,680,517 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $37,790,336 | 1,062,123 | SOLE | |||
| Edgewise Therapeutics, Inc. | COM | 28036F105 | $34,053,879 | 3,112,786 | SOLE | |||
| Sera Prognostics, Inc. | CLASS A COM | 81749D107 | $32,497,706 | 5,434,399 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $32,370,251 | 1,790,390 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $30,672,301 | 3,691,011 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $30,621,939 | 2,108,949 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $27,775,937 | 4,916,095 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $23,579,928 | 1,691,530 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $21,082,012 | 169,934 | SOLE | |||
| Gracell Biotechnologies Inc. | SPONSORED ADS | 38406L103 | $20,883,200 | 2,080,000 | SOLE | |||
| Immunovant, Inc. | COM | 45258J102 | $17,905,629 | 425,009 | SOLE | |||
| TScan Therapeutics, Inc. | COM | 89854M101 | $16,235,337 | 2,784,792 | SOLE | |||
| Day One Biopharmaceuticals, Inc. | COM | 23954D109 | $14,600,000 | 1,000,000 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $13,924,471 | 14,614,264 | SOLE | |||
| Relay Therapeutics, Inc. | COM | 75943R102 | $12,772,888 | 1,160,117 | SOLE | |||
| ARS Pharmaceuticals, Inc. | COM | 82835W108 | $10,995,351 | 2,006,451 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $10,678,505 | 2,030,134 | SOLE | |||
| 2seventy bio, Inc. | COM | 901384107 | $10,664,436 | 2,497,526 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $10,629,570 | 343,000 | SOLE | |||
| Celldex Therapeutics, Inc. | COM | 15117B202 | $9,821,561 | 247,644 | SOLE | |||
| Prime Medicine, Inc. | COM | 74168J101 | $9,112,209 | 1,028,466 | SOLE | |||
| Neurogene Inc. | COM | 64135M105 | $8,789,140 | 453,516 | SOLE |